It showed that these two genes, FN1 and THBS1, were significantly associated with the prognosis of NSCLC, especially with the prognosis of radiotherapy and could potentially be an indicator to assess the efficacy of NSCLC after radiotherapy. Here, THBS1 is linked to non-small cell lung carcinoma.